Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets

Journal of Molecular Graphics and Modelling

Volumn 48, Issue , 2014, Pages 105-117

  Ogungbe, Ifedayo Victor ^a   Erwin, William R ^b   Setzer, William N ^b  

^a JACKSON STATE UNIVERSITY   (United States)

^b University of Alabama in Huntsville   (United States)

Author keywords

Aurone; Chalcone; Coumarin; Flavonoid; Lignan; Stilbenoid

Indexed keywords

AURONE; CHALCONES; COUMARIN; FLAVONOID; LIGNAN; STILBENOID;

FLAVONOIDS; PROTEINS;

MOLECULAR MODELING;

ANTILEISHMANIAL AGENT; AURONE DERIVATIVE; CANNABINOID DERIVATIVE; CATHEPSIN B; CHALCONE DERIVATIVE; CHROMENE DERIVATIVE; COUMARIN DERIVATIVE; CYCLOPHILIN; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DIHYDROOROTATE DEHYDROGENASE; ISOFLAVONOID; LIGNAN DERIVATIVE; METHIONINE TRANSFER RNA LIGASE; MICROBIAL ENZYME; NUCLEOSIDASE; OLIGOPEPTIDASE B; PHENOL DERIVATIVE; PHOSPHODIESTERASE; PHOSPHODIESTERASE B1; PLANT MEDICINAL PRODUCT; PROTEIN N MYRISTOYLTRANSFERASE; PTERIDINE DERIVATIVE; PTERIDINE REDUCTASE 1; QUINONE DERIVATIVE; SERINE PROTEINASE; STEROL 14ALPHA DEMETHYLASE; STILBENE DERIVATIVE; TYROSINE TRANSFER RNA LIGASE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; XANTHONE DERIVATIVE;

ARTICLE; COMPUTER MODEL; DIELECTRIC CONSTANT; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING;

AURONE; CHALCONE; COUMARIN; FLAVONOID; LIGNAN; STILBENOID;

AMINO ACID MOTIFS; ANTIPROTOZOAL AGENTS; BINDING SITES; HYDROGEN BONDING; LEISHMANIA; MOLECULAR DOCKING SIMULATION; PLANT EXTRACTS; POLYPHENOLS; PROTOZOAN PROTEINS;

EID: 84893084627     PISSN: 10933263     EISSN: 18734243     Source Type: Journal    
DOI: 10.1016/j.jmgm.2013.12.010     Document Type: Article

References (123)

1. J. Alvar, I.D. Vélez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, M. den Boer the WHO Leishmaniasis Control Team Leishmaniasis worldwide and global estimates of its incidence PLoS ONE 7 5 2012 e35671
2. L. Stockdale, and R. Newton A review of preventative methods against human leishmaniasis infection PLoS Negl. Trop. Dis. 7 6 2013 e2278
3. J. Arevalo, L. Ramirez, V. Adaui, M. Zimic, G. Tulliano, C. Miranda-Verástegui, M. Lazo, R. Loayza-Muro, S. De Doncker, A. Maurer, F. Chappuis, J.C. Dujardin, and A. Llanos-Cuentas Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis J. Infect. Dis. 195 2007 1846 1851 (Pubitemid 46870258)
4. S.L. Croft, S. Sundar, and A.H. Fairlamb Drug resistance in leishmaniasis Clin. Microbiol. Rev. 19 2006 111 126 (Pubitemid 43157649)
5. H. Goto, and J.A.L. Lindoso Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis Exp. Rev. Anti-Infect. Ther. 8 2010 419 433
6. S. Sundar, T.K. Jha, C.P. Thakur, J. Engel, H. Sindermann, C. Fischer, K. Junge, A. Bryceson, and J. Berman Oral miltefosine for Indian visceral leishmaniasis New Engl. J. Med. 347 2002 1739 1746 (Pubitemid 35375612)
7. J. Alvar, S.L. Croft, P. Kaye, A. Khamesipour, S. Sundar, and S.G. Reed Case study for a vaccine against leishmaniasis Vaccine 31 2013 B244 B249
8. R.B. Jacob, T. Anderson, and O.M. McDougal Accessible high-throughput virtual screening molecular docking software for students and educators PLoS Comput. Biol. 8 2012 e1002499
9. X.Y. Meng, H.X. Zhang, M. Mezei, and M. Cui Molecular docking: a powerful approach for structure-based drug discovery Curr. Comput. Aided Drug Des. 7 2011 146 157
10. H.L. Brielmann, W.N. Setzer, P.B. Kaufman, A. Kirakosyan, and L.J. Cseke Phytochemicals: the chemical components of plants L.J. Cseke, A. Kirakosyan, P.B. Kaufman, S.L. Warber, J.A. Duke, H.L. Brielmann, Natural Products from Plants 2nd ed. 2006 CRC Press Boca Raton, Florida 1 49
11. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220 (Pubitemid 127696281)
12. L.M. Hung, J.K. Chen, S.S. Huang, R.S. Lee, and M.J. Su Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc. Res. 47 2000 549 555
13. A.Y. Sun, Q. Wang, A. Simonyi, and G.Y. Sun Resveratrol as a therapeutic agent for neurodegenerative diseases Mol. Neurobiol. 41 2010 375 383
14. M.G.L. Hertog, P.C.H. Hollman, and B. van de Putte Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices J. Agric. Food Chem. 41 1993 1242 1246
15. B. Sultana, and F. Anwar Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants Food Chem. 108 2008 879 884
16. K. Murota, and J. Terao Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism Arch. Biochem. Biophys. 417 2003 12 17 (Pubitemid 36960043)
17. M.G.L. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljkovic, M. Pekkarinen, B.S. Simic, H. Toshima, E.J.M. Feskens, P.C.H. Hollman, and M.B. Katan Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study Arch. Intern. Med. 155 1995 381 386
18. E. Middleton, C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
19. R.A. Dixon, and D. Ferreira Genistein Phytochemistry 60 2002 205 211 (Pubitemid 34947527)
20. P. McCue, and K. Shetty Health benefits of soy isoflavonoids and strategies for enhancement: a review Crit. Rev. Food Sci. Nutr. 44 2004 361 367 (Pubitemid 39357993)
21. M.J. Chan-Bacab, and L.M. Peña-Rodríquez Plant natural products with leishmanicidal activity Nat. Prod. Rep. 18 2001 674 688 (Pubitemid 34010018)
22. O. Kayser, A.F. Kiderlen, and S.L. Croft Natural products as antiparasitic drugs Parasitol. Res. 90 2003 S55 S62
23. L.G. Rocha, J.R.G.S. Almeida, R.O. Macêdo, and J.M. Barbosa-Filho A review of natural products with antileishmanial activity Phytomedicine 12 2005 514 535 (Pubitemid 40755130)
24. M.M. Salem, and K.A. Werbovetz Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis Curr. Med. Chem. 13 2006 2571 2598 (Pubitemid 44364157)
25. W.N. Setzer, and M.C. Setzer Antitrypanosomal agents from higher plants L.A.D. Williams, Biologically Active Natural Products for the 21st Century 2006 Research Signpost Trivandrum, India 47 95
26. N. Uchiyama Antichagasic activities of natural products against Trypanosoma cruzi J. Health Sci. 55 2009 31 39
27. E. Izumi, T. Ueda-Nakamura, B.P.D. Filho, V.F.V. Júnior, and C.V. Nakamura Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi Nat. Prod. Rep. 28 2011 809 823
28. I.V. Ogungbe, M. Singh, and W.N. Setzer Antileishmanial natural products from plants Stud. Nat. Prod. Chem. 36 2012 331 382
29. T.J. Schmidt, S.A. Khalid, A.J. Romanha, T.M.A. Alves, M.W. Biavatti, R. Brun, F.B. Da Costa, S.L. de Castro, V.F. Ferreira, M.V.G. de Lacerda, J.H.G. Lago, L.L. Leon, N.P. Lopes, R.C. das Neves Amorim, M. Niehues, I.V. Ogungbe, A.M. Pohlit, M.T. Scotti, W.N. Setzer, M.d.N.C. Soeiro, M. Steindel, and A.G. Tempone The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - Part II Curr. Med. Chem. 19 2012 2176 2228
30. Molegro Virtual Docker version 6.0.0 2013 Molegro ApS Aarhus, Denmark
31. R. Thomsen, and M.H. Christensen MolDock: a new technique for high-accuracy molecular docking J. Med. Chem. 49 2006 3315 3321 (Pubitemid 43830529)
32. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
33. I.D. Kerr, P. Wu, R. Marion-Tsukamaki, Z.B. Mackey, and L.S. Brinen Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei PLoS Negl. Trop. Dis. 4 6 2010 e701
34. A.T. Cordeiro, P.R. Feliciano, M.C. Nonato, Crystal structure of Leishmania major dihydroorotate dehydrogenase, to be published, http://dx.doi.org/10.2210/pdb3gye/pdb.
35. J. Cheleski, J.R. Rocha, M.P. Pinheiro, H.J. Wiggers, A.B.F. da Silva, M.C. Nonato, and C.A. Montanari Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery Eur. J. Med. Chem. 45 2010 5899 5909
36. E.T. Larson, J.E. Kim, F.H. Zucker, A. Kelley, N. Mueller, A.J. Napuli, C.L. Verlinde, E. Fan, F.S. Buckner, W.C. Van Voorhis, E.A. Merritt, and W.G.J. Hol Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphate Biochimie 93 2011 570 582
37. T. Seebeck, K.W. Gong, S. Kunz, R. Schaub, T. Shalaby, and R. Zorghi cAMP signaling in Trypanosoma brucei Int. J. Parasitol. 31 2001 491 498
38. W. Shi, V.L. Schramm, and S.C. Almo Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-Å crystal structure J. Biol. Chem. 274 1999 21114 21120
39. J.A. Frearson, S. Brand, S.P. McElroy, L.A. Cleghorn, O. Smid, L. Stojanovski, H.P. Price, M.L. Guther, L.S. Torrie, D.A. Robinson, I. Hallyburton, C.P. Mpamhanga, J.A. Brannigan, A.J. Wilkinson, M. Hodgkinson, R. Hui, W. Qiu, O.G. Raimi, D.M. van Aalten, R. Brenk, I.H. Gilbert, K.D. Read, A.H. Fairlamb, M.A. Ferguson, D.F. Smith, and P.G. Wyatt N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness Nature 464 2010 728 732
40. S. Brand, L.A. Cleghorn, S.P. McElroy, D.A. Robinson, V.C. Smith, I. Hallyburton, J.R. Harrison, N.R. Norcross, D. Spinks, T. Bayliss, S. Norval, L. Stojanovski, L.S. Torrie, J.A. Frearson, R. Brenk, A.H. Fairlamb, M.A. Ferguson, K.D. Read, P.G. Wyatt, and I.H. Gilbert Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors J. Med. Chem. 55 2012 140 152
41. K. McLuskey, N.G. Paterson, N.D. Bland, N.W. Isaacs, and J.C. Mottram Crystal structure of Leishmania major oligopeptidase B gives insight into the enzymatic properties of a trypanosomatid virulence factor J. Biol. Chem. 285 2010 39249 39259
42. H. Wang, Z. Yan, J. Geng, S. Kunz, T. Seebeck, and H. Ke Crystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitors Mol. Microbiol. 66 2007 1029 1038 (Pubitemid 350050428)
43. K. McLuskey, F. Gibellini, P. Carvalho, M.A. Avery, and W.N. Hunter Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex Acta Crystallogr. D60 2004 1780 1785 (Pubitemid 41079699)
44. A.W. Schüttelkopf, L.W. Hardy, S.M. Beverley, and W.N. Hunter Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design J. Mol. Biol. 352 2005 105 116 (Pubitemid 41207443)
45. A. Cavazzuti, G. Paglietti, W.N. Hunter, F. Gamarro, S. Piras, M. Loriga, A. Allecca, P. Corona, K. McLuskey, L. Tulloch, F. Gibellini, S. Ferrari, and M.P. Costi Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development Proc. Natl. Acad. Sci. U.S.A. 105 2008 1448 1453 (Pubitemid 351346534)
46. E.T. Larson, J.E. Kim, L.J. Castaneda, A.J. Napuli, Z. Zhang, E. Fan, F.H. Zucker, C.L. Verlinde, F.S. Buckner, W.C. Van Voorhis, W.G. Hol, and E.A. Merritt The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimer J. Mol. Biol. 409 2011 159 176
47. T. Steiner, A.C. Lamerz, P. Hess, C. Breithaupt, S. Krapp, G. Bourenkov, R. Huber, R. Gerardy-Schahn, and U. Jacob Open and closed structures of the UDP-glucose pyrophosphorylase from Leishmania major J. Biol. Chem. 282 2007 13003 13010 (Pubitemid 47100592)
48. G.R. Hemsworth, O.V. Moroz, M.J. Fogg, B. Scott, C. Bosch-Navarrete, D. González-Pacanowska, and K.S. Wilson The crystal structure of the Leishmania major deoxyuridine triphosphate nucleotidohydrolase in complex with nucleotide analogues, dUMP, and deoxyuridine J. Biol. Chem. 286 2011 16470 16481
49. V. Venugopal, B. Sen, A.K. Datta, and R. Banerjee Structure of cyclophilin from Leishmania donovani at 1.97 Å resolution Acta Crystallogr. F63 2007 60 64 (Pubitemid 46276917)
50. V. Venugopal, A.K. Datta, D. Bhattacharyya, D. Dasgupta, and R. Banerjee Structure of cyclophilin from Leishmania donovani bound to cyclosporin at 2.6 Å resolution: correlation between structure and thermodynamic data Acta Crystallogr. D65 2009 1187 1195
51. T.L. Arakaki, E.A. Merritt, B. Ullman, P.A. Yates, Crystal structure of dihydroorotate dehydrogenase from Leishmania donovani, to be published, http://dx.doi.org/10.2210/pdb3c61/pdb.
52. J.A. Brannigan, B.A. Smith, Z. Yu, A.M. Brzozowski, M.R. Hodgkinson, A. Maroof, H.P. Price, F. Meier, R.J. Leatherbarrow, E.W. Tate, D.F. Smith, and A.J. Wilkinson N-Myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis J. Mol. Biol. 396 2010 985 999
53. H. Kim, and W.G. Hol Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure J. Mol. Biol. 278 1998 5 11 (Pubitemid 28196147)
54. H. Kim, I.K. Feil, C.L. Verlinde, P.H. Petra, and W.G. Hol Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site Biochemistry 34 1995 14975 14986
55. S. Suresh, S. Turley, F.R. Opperdoes, P.A. Michels, and W.G. Hol A potential target enzyme for trypanocidal drugs revealed by the crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania mexicana Structure 8 2000 541 552 (Pubitemid 30304551)
56. J. Choe, S. Suresh, G. Wisedchaisri, K.J. Kennedy, M.H. Gelb, and W.G. Hol Anomalous differences of light elements in determining precise binding modes of ligands to glycerol-3-phosphate dehydrogenase Chem. Biol. 9 2002 1189 1197 (Pubitemid 35352771)
57. A.T. Cordeiro, P.A. Michels, L.F. Delboni, and O.H. Thiemann The crystal structure of glucose-6-phosphate isomerase from Leishmania mexicana reveals novel active site features Eur. J. Biochem. 271 2004 2765 2772 (Pubitemid 38869977)
58. L. Kedzierski, R.L. Malby, B.J. Smith, M.A. Perugini, A.N. Hodder, T. Ilg, P.M. Colman, and E. Handman Structure of Leishmania mexicana phosphomannomutase highlights similarities with human isoforms J. Mol. Biol. 363 2006 215 227 (Pubitemid 44437564)
59. D.J. Rigden, S.E.V. Phillips, P.A.M. Michels, and L.A. Fothergill-Gilmore The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity J. Mol. Biol. 291 1999 615 635 (Pubitemid 29392638)
60. H.P. Morgan, I.W. McNae, M.W. Nowicki, V. Hannaert, P.A. Michels, L.A. Fothergill-Gilmore, and M.D. Walkinshaw Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model J. Biol. Chem. 285 2010 12892 12898
61. H.P. Morgan, I.W. McNae, M.W. Nowicki, W. Zhong, P.A. Michels, D.S. Auld, L.A. Fothergill-Gilmore, and M.D. Walkinshaw The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site J. Biol. Chem. 286 2011 31232 31240
62. M. Alahuhta, and R.K. Wierenga Atomic resolution crystallography of a complex of triosephosphate isomerase with a reaction-intermediate analog: new insight in the proton transfer reaction mechanism Proteins 78 2010 1878 1888
63. R. Venkatesan, M. Alahuhta, P.M. Pihko, and R.K. Wierenga High resolution crystal structures of triosephosphate isomerase complexed with its suicide inhibitors: the conformational flexibility of the catalytic glutamate in its closed, liganded active site Protein Sci. 20 2011 1387 1397
64. T.Y. Hargrove, Z. Wawrzak, J. Liu, W.D. Nes, M.R. Waterman, and G.I. Lepesheva Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14α-demethylase (CYP51) from Leishmania infantum J. Biol. Chem. 286 2011 26838 26848
65. M.S. Silva, L. Barata, A.E.N. Ferreira, S. Romão, A.M. Tomás, A.P. Freire, and C. Cordeiro Catalysis and structural properties of Leishmania infantum glyoxalase II: trypanothione specificity and phylogeny Biochemistry 47 2008 195 204
66. + production and parasite proliferation Mol. Microbiol. 82 2011 21 38
67. P.K. Fyfe, G.D. Westrop, A.M. Silva, G.H. Coombs, and W.N. Hunter Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation Proc. Natl. Acad. Sci. U.S.A. 109 2012 11693 11698
68. A. Ilari, P. Baiocco, L. Messori, A. Fiorillo, A. Boffi, M. Gramiccia, T. Di Muccio, and G. Colotti A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition Amino Acids 42 2012 803 811
69. P. Baiocco, G. Poce, S. Alfonso, M. Cocozza, G.C. Porretta, G. Colotti, M. Biava, F. Moraca, M. Botta, V. Yardley, A. Fiorillo, A. Lantella, F. Malatesta, and A. Ilari Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography ChemMedChem 8 2013 1175 1183
70. Spartan '10 for Windows, version 1.1 2011 Wavefunction, Inc. Irvine, California
71. T.A. Halgren Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF 94 J. Comput. Chem. 17 1996 490 519
72. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallogr. D50 1994 760 763
73. N. Stein CHAINSAW: a program for mutating pdb files used as templates in molecular replacement J. Appl. Crystallogr. 41 2008 641 643 (Pubitemid 351693895)
74. A.T. Brünger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, R.J. Read, L.M. Rice, T. Simonson, and G.L. Warren Crystallography & NMR System: a new software suite for macromolecular structure determination Acta Crystallogr. D54 1998 905 921
75. C.R. Caffrey, and D. Steverding Kinetoplastid papain-like cysteine peptidases Mol. Biochem. Parasitol. 167 2009 12 19
76. M.P. Pinheiro, F.D.S. Emery, and M.C. Nonato Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase Curr. Pharmaceut. Design 19 2013 2615 2627
77. A.A. da Silva Filho, S. Albuquerque, M.L. Silva, M.N. Eberlin, D.M. Tomazela, and J.K. Bastos Tetrahydrofuran lignans from Nectandra megapotamica with trypanocidal activity J. Nat. Prod. 67 2004 42 45 (Pubitemid 38141308)
78. M.M. Radwan, M.A. ElSohly, D. Slade, S.A. Ahmed, I.A. Khan, and S.A. Ross Biologically active cannabinoids from high-potency Cannabis sativa J. Nat. Prod. 72 2009 906 911
79. T. Narender, Shweta, K. Tanvir, M.S. Rao, K. Srivastava, and S.K. Puri Prenylated chalcones isolated from Crotalaria genus inhibits in vitro growth of the human malaria parasite Plasmodium falciparum Bioorg. Med. Chem. Lett. 15 2005 2453 2455 (Pubitemid 40614969)
80. Y.C. Kim, H.S. Kim, Y. Wataya, D.H. Sohn, T.H. Kang, M.S. Kim, Y.M. Kim, G.M. Lee, J.D. Chang, and H. Park Antimalarial activity of lavandulyl flavanones isolated from the roots of Sophora flavescens Biol. Pharm. Bull. 27 2004 748 750 (Pubitemid 41694686)
81. C. Nguyen, G. Kasinathan, I. Leal-Cortijo, A. Musso-Buendia, M. Kaiser, R. Brun, L.M. Ruiz-Pérez, N.G. Johansson, D. González-Pacanowska, and I.H. Gilbert Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target J. Med. Chem. 48 2005 5942 5954 (Pubitemid 41324605)
82. T.A.C.B. Souza, D.M. Trindade, C.C.C. Tonoli, C.R. Santos, R.J. Ward, R.K. Arni, A.H.C. Oliveira, and M.T. Murakami Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: stability, oligomerization and structural determinants of nucleotide binding Mol. BioSyst. 7 2011 2189 2195
83. B.K. Kolli, J. Kostal, O. Zaborina, A.M. Chakrabarty, and K.P. Chang Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages Mol. Biochem. Parasitol. 158 2008 163 175 (Pubitemid 351248780)
84. I.L. Buxton Inhibition of Nm23H2 gene product (NDPK-B) by angiostatin, polyphenols and nucleoside analogs Proc. West Pharmacol. Soc. 51 2008 30 34
85. M. Berg, P. Van der Veken, A. Goeminne, A. Haemers, and K. Augustyns Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy? Curr. Med. Chem. 17 2010 2456 2481
86. M.N. Rennó, T.C. França, D. Nico, C.B. Palatnik-de-Sousa, L.W. Tinoco, and J.D. Figueroa-Villar Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani Eur. J. Med. Chem. 56 2012 301 307
87. M. Berg, G. Bal, A. Goeminne, P. Van der Veken, W. Versées, J. Steyaert, A. Haemers, and K. Augustyns Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors ChemMedChem 4 2009 249 260
88. H.P. Price, M.R. Menon, C. Panethymitaki, D. Goulding, P.G. McKean, and D.F. Smith Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites J. Biol. Chem. 278 2003 7206 7214 (Pubitemid 36800720)
89. C. Boonlaksiri, W. Oonanant, P. Kongsaeree, P. Kittakoop, M. Tanticharoen, and Y. Thebtaranonth An antimalarial stilbene from Artocarpus integer Phytochemistry 54 2000 415 417 (Pubitemid 30418962)
90. M.M. Salem, J. Capers, S. Rito, and K.A. Werbovetz Antiparasitic activity of C-geranyl flavonoids from Mimulus bigelovii Phytother. Res. 25 2011 1246 1249
91. C.O. Jordão, W. Vichnewski, G.E. de Souza, S. Albuquerque, and J.L. Lopes Trypanocidal activity of chemical constituents from Lychnophora salicifolia Mart. Phytother. Res. 18 2004 332 334 (Pubitemid 38619537)
92. J.C. Munday, K. McLuskey, E. Brown, G.H. Coombs, and J.C. Mottram Oligopeptidase B deficient mutants of Leishmania major Mol. Biochem. Parasitol. 175 2011 49 57
93. A.W. Andayi, A. Yenesew, S. Derese, J.O. Midiwo, P.M. Gitu, O.J. Jondiko, H. Akala, P. Liyala, J. Wangui, N.C. Waters, M. Heydenreich, and M.G. Peter Antiplasmodial flavonoids from Erythrina sacleuxii Planta Med. 72 2006 187 189 (Pubitemid 43293877)
94. T. Seebeck, G.J. Sterk, and H. Ke Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite Future Med. Chem. 3 2011 1289 1306
95. A. Johner, S. Kunz, M. Linder, Y. Shakur, and T. Seebeck Cyclic nucleotide specific phosphodiesterases of Leishmania major BMC Microbiol. 6 2006 25
96. I. Muhammad, X.C. Li, D.C. Dunbar, M.A. ElSohly, and I.A. Khan Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum J. Nat. Prod. 64 2001 1322 1325 (Pubitemid 33029215)
97. I. Muhammad, X.C. Li, M.R. Jacob, B.L. Tekwani, D.C. Dunbar, and D. Ferreira Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum J. Nat. Prod. 66 2003 804 809 (Pubitemid 36782089)
98. U. Namdaung, N. Aroonrerk, S. Suksamrarn, K. Danwisetkanjana, J. Saenboonrueng, W. Arjchomphu, and A. Suksamrarn Bioactive constituents of the root bark of Artocarpus rigidus subsp. rigidus Chem. Pharm. Bull. 54 2006 1433 1436 (Pubitemid 44506578)
99. P. Corona, F. Gibellini, A. Cavalli, P. Saxena, A. Carta, M. Loriga, R. Luciani, G. Paglietti, D. Guerrieri, E. Nerini, S. Gupta, V. Hannaert, P.A.M. Michels, S. Ferrari, and P.M. Costi Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors J. Med. Chem. 55 2012 8318 8329
100. L.G. Felippe, D.C. Baldoqui, M.J. Kato, V.d.S. Bolzani, E.F. Guimarães, R.M. Cicarelli, and M. Furlan Trypanocidal tetrahydrofuran lignans from Peperomia blanda Phytochemistry 69 2008 445 450
101. A. Suzuki, O. Shirota, K. Mori, S. Sekita, H. Fuchino, A. Takano, and M. Kuroyanagi Leishmanicidal active constituents from Nepalese medicinal plant Tulsi (Ocimum sanctum L.) Chem. Pharm. Bull. 57 2009 245 251
102. M. Ibba, and D. Soll Aminoacyl-tRNA synthesis Annu. Rev. Biochem. 69 2000 617 650
103. S. Shibata, J.R. Gillespie, A.M. Kelley, A.J. Napuli, Z. Zhang, K.V. Kovzun, R.M. Pefley, J. Lam, F.H. Zucker, W.C. Van Voorhis, E.A. Merritt, W.G.J. Hol, C.L.M.J. Verlinde, E. Fan, and F.S. Buckner Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei infection in mice Antimicrob. Agents Chemother. 55 2011 1982 1989
104. R. Das, A. Roy, N. Dutta, and H.K. Majumder Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani Apoptosis 13 2008 867 882
105. N. Adapala, and M.M. Chan Long-term use of an anti-inflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model Lab. Invest. 88 2008 1329 1339
106. N.C. Vieira, L.S. Espíndola, J.M. Santana, M.L. Veras, O.D.L. Pessoa, S.M. Pinheiro, R.M. de Araújo, M.A.S. Lima, and E.R. Silveira Trypanocidal activity of a new pterocarpan and other secondary metabolites of plants from northeastern Brazil flora Bioorg. Med. Chem. 16 2008 1676 1682 (Pubitemid 351226598)
107. O. Kayser, A.F. Kiderlen, and R. Brun In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54 Planta Med. 67 2001 718 721 (Pubitemid 33044477)
108. A.C. Lamerz, S. Damerow, B. Kleczka, M. Wiese, G. van Zandbergen, J. Lamerz, A. Wenzel, F.F. Hsu, J. Turk, S.M. Beverly, and F.H. Routier Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major Glycobiology 20 2010 872 882
109. V. Yurchenko, Z. Xue, B. Sherry, and M. Bukrinsky Functional analysis of Leishmania major cyclophilin Int. J. Parasitol. 38 2008 633 639 (Pubitemid 351452023)
110. W.L. Yau, T. Blisnick, J.F. Taly, M. Helmer-Citterich, C. Schiene-Fischer, O. Leclercq, J. Li, D. Schmidt-Arras, M.A. Morales, C. Notredame, D. Romo, P. Bastin, and G.F. Späth Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability PLoS Negl. Trop. Dis. 4 6 2010 e729
111. M.M. Radwan, S.A. Ross, D. Slade, S.A. Ahmed, F. Zulfiqar, and M.A. ElSohly Isolation and characterization of new Cannabis constituents from a high potency variety Planta Med. 74 2008 267 272 (Pubitemid 351449950)
112. G.I. Lepesheva, and M.R. Waterman Sterol 14α-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis Curr. Top. Med. Chem. 11 2011 2060 2071
113. W.N. Setzer, and I.V. Ogungbe In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants PLoS Negl. Trop. Dis. 6 7 2012 e1727
114. I.V. Ogungbe, and W.N. Setzer In-silico Leishmania target selectivity of antiparasitic terpenoids Molecules 18 2013 7761 7847
115. T.Y. Hargrove, Z. Wawrzak, J. Liu, M.R. Waterman, W.D. Nes, and G.I. Lepesheva Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-δ7-24,25-dihydrolanosterol J. Lipid Res. 53 2012 311 320
116. H.B. Lee, C.H. Lim, H.J. Kwon, Y.K. Kim, H.S. Lee, and C.J. Kim Inhibitory activity of diacylglycerol acyltransferase by cochlioquinones A and A1 J. Antibiot. (Tokyo) 56 2003 967 969 (Pubitemid 37508668)
117. T. Fujioka, K. Yao, K. Hamano, T. Hosoya, T. Kagasaki, Y. Furukawa, H. Haruyama, S. Sato, T. Koga, and Y. Tsujita Epi-cochlioquinone A, a novel acyl-CoA: cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi J. Antibiot. (Tokyo) 49 1996 409 413
118. M. Bezabih, B.M. Abegaz, K. Dufall, K. Croft, T. Skinner-Adams, and T.M. Davis Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata Planta Med. 67 2001 340 344 (Pubitemid 32588570)
119. P. Baiocco, S. Franceschini, A. Ilari, and G. Colotti Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis Prot. Peptide Lett. 16 2009 196 200
120. G. Colotti, and A. Ilari Polyamine metabolism in Leishmania: from arginine to trypanothione Amino Acids 40 2011 269 285
121. L.S. Bernardes, C.L. Zani, and I. Carvalho Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery Curr. Med. Chem. 20 2013 2673 2696
122. S. Marché, P.A.M. Michels, and F.R. Opperdoes Comparative study of Leishmania mexicana and Trypanosoma brucei NAD-dependent glycerol-3-phosphate dehydrogenase Mol. Biochem. Parasitol. 106 2000 83 91 (Pubitemid 30089212)
123. B. Chawla, and R. Madhubala Drug targets in Leishmania J. Parasit. Dis. 34 2010 1 13